Skip to main content

Pharmaceutical Desiccant Market worth USD 195.89 million by 2028, registering a CAGR of 4.71% – Report by Market Research Future (MRFR)

New York, Sept. 24, 2021 (GLOBE NEWSWIRE) — Pharmaceutical Desiccant Market Overview: According to a comprehensive research report by Market Research Future (MRFR), Pharmaceutical Desiccant Market Research Report, type, end-user and Region – Forecast till 2028” the market is projected to be worth USD 195.89 million by 2028, registering a CAGR of 4.71% during the forecast period (2021 – 2028).

Market Competitive Landscape:

List of the key competitors of the global Pharmaceutical Desiccant Market are listed as follows:

  • Multisorb Technologies (U.S.)
  • Desican Inc (U.S.)
  • CSP Technologies, Inc (U.S.)
  • R. Grace & Co (U.S.)
  • Sanner GmbH (Germany)
  • Capitol Scientific, Inc (U.S.)
  • I. du Pont de Nemours and Company (U.S.)
  • Oker-Chemie GmbH (Germany)
  • Desiccare, Inc (U.S.)
  • Clariant Global (Switzerland)
  • Among others.


Get Free Sample PDF Brochure
https://www.marketresearchfuture.com/sample_request/4182


Market Research Future’s Review on Pharmaceutical Desiccant Market

Desiccants are materials that aid in the absorption of moisture as well as introduce the optimum amount of dryness in the environment around the substances. In nature, they are both soluble and insoluble. These assist in removing excess humidity and have increasingly found their way into the pharmaceutical business. The global pharmaceutical desiccant market value is expanding swiftly as a result of widespread use for quality and strength preservation.

Market USP Covered:

Drivers:

There is a significant increase in the aging population, a broadening of pharmaceutical business trends, and government intervention and initiatives. This would assure high-quality medical pharmaceuticals, which will be a major driver of the global pharmaceutical desiccant market growth.

Restraints:

The pharmaceutical desiccant market is being restricted by the implementation of stringent standards and fluctuating conditions. Pharmaceutical items must meet stringent quality control and performance standards. Desiccant suppliers must comply with pharmaceutical firms’ quality management systems on a regular basis.  The other factor hindering the pharmaceutical desiccants market growth is their unpredictable performance at different temperatures depending on their type. The temperature required by the product must determine the desiccant’s temperature.


Browse In-depth Market Research Report (185 pages) on Pharmaceutical Desiccant 

https://www.marketresearchfuture.com/reports/pharmaceutical-desiccant-market-4182


COVID-19 Analysis:

The pharmaceutical business has witnessed an unsettling slowdown in growth as a result of the global pandemic of COVID-19. Due to marketing difficulties in several geographical regions around the world, the pharmaceutical desiccant market is undergoing an economic downturn. The pharmaceutical desiccant market growth is susceptible to the country’s economic growth in which it is located. Following the global spread of the coronavirus, there has been a new influx of drugs on the market, exacerbating the slowdown.

Market Segmentation:

The segmentation of the global pharmaceutical desiccants market is done by type and end-user. By type, the majority of the pharmaceutical desiccant market share is held by silica gel. This is because it is non-flammable, non-toxic, and porous in nature. By end-user, the tablets segment held the largest market share in the global market.

Regional Insights:
The APAC region is witnessing the highest pharmaceutical market growth on a global scale. The anticipated CAGR of this region is 4.77% due to a rise in manufacturing activities and an increase in the population of people requiring pharmaceutical desiccants. The market growth can be attributed to increased pharmaceutical desiccant output in China as well as a better utilization rate of the commodity in Chinese plants than in facilities in developed countries. China’s elevated pharmaceutical desiccant is now employed as a matting reagent for plastics, paints, catalysts, and other anti-adhesives.

North America holds the highest pharmaceutical market share in the world, owing to the region’s strong pharmaceutical manufacturing base, favorable government regulations, and significant R&D expenditure. In 2018, North America had a market share of approximately 38%.


Share your Queries
https://www.marketresearchfuture.com/enquiry/4182

During the forecast period of 2019 to 2027, the European market for pharmaceutical desiccants is anticipated to expand at a CAGR of 4.59%. The pharmaceutical industry’s ever-increasing growth has aided in the expansion of the pharmaceutical desiccant market size. Economic benefits and increased disposable incomes have mostly led to the pharmaceutical market’s rapid growth. Additionally, increased income levels, particularly for those in the lowest economic strata, as well as government measures to offer basic healthcare facilities, are predicted to boost the availability and affordability of pharmaceuticals for the population. This is predicted to stimulate the pharmaceutical industry’s growth, resulting in higher use of pharmaceutical desiccants.

Segmentation of Market covered in the research:

Pharmaceutical Desiccant Market Information Report, By Type (Silica Gel, Activated, Carbonclay Desiccant, Molecular Sieves and Others), By End-Use (Tablets, API’s, Capsules, Diagnostic Kit  and Nutraceutical Product Packaging), and By Region – Forecast to 2028

To Buy:  https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=4182


About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter

CONTACT: Contact:
Market Research Future

Phone:
+1 628 258 0071(US)  
+44 2035 002 764(UK)

Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.